Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru

We conducted a retrospective cohort study of children who had chronic fascioliasis in the highlands of Peru to determine triclabendazole treatment efficacy. Children passing Fasciola eggs in stool were offered directly observed triclabendazole treatment (>1 doses of 10 mg/kg). Parasitologic cure...

Full description

Bibliographic Details
Main Authors: Maria L. Morales, Melinda B. Tanabe, A. Clinton White, Martha Lopez, Ruben Bascope, Miguel M. Cabada
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-07-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/27/7/20-3900_article
_version_ 1828951004248276992
author Maria L. Morales
Melinda B. Tanabe
A. Clinton White
Martha Lopez
Ruben Bascope
Miguel M. Cabada
author_facet Maria L. Morales
Melinda B. Tanabe
A. Clinton White
Martha Lopez
Ruben Bascope
Miguel M. Cabada
author_sort Maria L. Morales
collection DOAJ
description We conducted a retrospective cohort study of children who had chronic fascioliasis in the highlands of Peru to determine triclabendazole treatment efficacy. Children passing Fasciola eggs in stool were offered directly observed triclabendazole treatment (>1 doses of 10 mg/kg). Parasitologic cure was evaluated by using microscopy of stool 1–4 months after each treatment. A total of 146 children who had chronic fascioliasis participated in the study; 53% were female, and the mean ± SD age was 10.4 ± 3.1 years. After the first treatment, 55% of the children achieved parasitologic cure. Cure rates decreased after the second (38%), third (30%), and fourth (23%) treatments; 17 children (11.6%) did not achieve cure after 4 treatments. Higher baseline egg counts and lower socioeconomic status were associated with triclabendazole treatment failure. Decreased triclabendazole efficacy in disease-endemic communities threatens control efforts. Further research on triclabendazole resistance and new drugs to overcome it are urgently needed.
first_indexed 2024-12-14T06:31:44Z
format Article
id doaj.art-c2befb7139c6493b875973951e187f2e
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-14T06:31:44Z
publishDate 2021-07-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-c2befb7139c6493b875973951e187f2e2022-12-21T23:13:30ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592021-07-012771850185710.3201/eid2707.203900Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, PeruMaria L. MoralesMelinda B. TanabeA. Clinton WhiteMartha LopezRuben BascopeMiguel M. CabadaWe conducted a retrospective cohort study of children who had chronic fascioliasis in the highlands of Peru to determine triclabendazole treatment efficacy. Children passing Fasciola eggs in stool were offered directly observed triclabendazole treatment (>1 doses of 10 mg/kg). Parasitologic cure was evaluated by using microscopy of stool 1–4 months after each treatment. A total of 146 children who had chronic fascioliasis participated in the study; 53% were female, and the mean ± SD age was 10.4 ± 3.1 years. After the first treatment, 55% of the children achieved parasitologic cure. Cure rates decreased after the second (38%), third (30%), and fourth (23%) treatments; 17 children (11.6%) did not achieve cure after 4 treatments. Higher baseline egg counts and lower socioeconomic status were associated with triclabendazole treatment failure. Decreased triclabendazole efficacy in disease-endemic communities threatens control efforts. Further research on triclabendazole resistance and new drugs to overcome it are urgently needed.https://wwwnc.cdc.gov/eid/article/27/7/20-3900_articletriclabendazoletreatment failurefascioliasisFasciola hepaticaliver fluketrematode
spellingShingle Maria L. Morales
Melinda B. Tanabe
A. Clinton White
Martha Lopez
Ruben Bascope
Miguel M. Cabada
Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
Emerging Infectious Diseases
triclabendazole
treatment failure
fascioliasis
Fasciola hepatica
liver fluke
trematode
title Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
title_full Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
title_fullStr Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
title_full_unstemmed Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
title_short Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
title_sort triclabendazole treatment failure for fasciola hepatica infection among preschool and school age children cusco peru
topic triclabendazole
treatment failure
fascioliasis
Fasciola hepatica
liver fluke
trematode
url https://wwwnc.cdc.gov/eid/article/27/7/20-3900_article
work_keys_str_mv AT marialmorales triclabendazoletreatmentfailureforfasciolahepaticainfectionamongpreschoolandschoolagechildrencuscoperu
AT melindabtanabe triclabendazoletreatmentfailureforfasciolahepaticainfectionamongpreschoolandschoolagechildrencuscoperu
AT aclintonwhite triclabendazoletreatmentfailureforfasciolahepaticainfectionamongpreschoolandschoolagechildrencuscoperu
AT marthalopez triclabendazoletreatmentfailureforfasciolahepaticainfectionamongpreschoolandschoolagechildrencuscoperu
AT rubenbascope triclabendazoletreatmentfailureforfasciolahepaticainfectionamongpreschoolandschoolagechildrencuscoperu
AT miguelmcabada triclabendazoletreatmentfailureforfasciolahepaticainfectionamongpreschoolandschoolagechildrencuscoperu